Reactions 1704, p328 - 2 Jun 2018 Diarrhoea: case report A 71-year-old man developed diarrhoea during treatment with pyridostigmine for acetylcholine receptor antibody- positive myasthenia gravis (MG) [duration of treatment to reaction onset and outcome not stated]. The man, who was diagnosed with acetylcholine receptor antibody-positive MG, started receiving oral pyridostigmine 120mg daily and tacrolimus. The symptoms of MG relieved. However, due to the subsequent disease progression, he was re-admitted and received treatment with methylprednisolone and immune globulin with an increased dose of tacrolimus. He developed diarrhoea secondary to pyridostigmine treatment. The man’s pyridostigmine treatment was discontinued. Further, he was diagnosed with small-cell lung cancer stage IVB and received chemoradiotherapy. He remained alive with no complaints and no disease progression to date. Author comment: "Pyridostigmine was stopped because the patient reported diarrhea as an adverse effect." Yamasaki M, et al. Acetylcholine receptor antibody-positive myasthenia gravis associated with small-cell lung cancer: A case report. Medicine 97: e0541, No. 17, Apr 2018. Available from: URL: http://doi.org/10.1097/MD.0000000000010541 - Japan 803322846 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704
Reactions Weekly – Springer Journals
Published: Jun 2, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera